Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In VitroYilin Dai, Yu Kang, Jing Xu et al.|International Journal of Molecular Sciences|2024Cited by 19
An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancerJing Xu, Congjian Xu, Ké Li et al.|Cancer Chemotherapy and Pharmacology|2022Cited by 16
A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical ReportYunke Huang, Yu Kang, Jing Xu et al.|Cancer Management and Research|2021Cited by 14
Chronic Stress Blocks the Endometriosis Immune Response by Metabolic ReprogrammingChong Lu, Yu Kang, Jing Xu et al.|International Journal of Molecular Sciences|2023Cited by 14
RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOCJing Xu, Congjian Xu, Yilin Dai et al.|International Journal of Molecular Sciences|2023Cited by 12